Steven Singer

Steven Singer has more than three decades of experience as a corporate attorney who has represented clients in a wide range of transactions. He has advised numerous public and private companies in the life sciences industry, focusing on joint ventures and strategic alliances, corporate and securities law, public offerings and venture capital transactions. Mr. Singer is consistently recognized in the areas of corporate and life sciences for successfully handling complex deals and collaborations in the technology transactions and licensing sector.

Practice

Mr. Singer has focused his practice in the life sciences industry for nearly three decades. He has served as counsel for public and private companies in the life sciences sector, including biotechnology, medical device and pharmaceutical companies. His practice focuses on joint ventures and strategic alliances, corporate and securities laws, public offerings and venture capital transactions.

Mr. Singer has worked with the following public company clients, among others: Achillion, Agios, Aveo, Catabasis, Cerulean, Curis, Editas, Infinity, Karyopharm and Syros. Representative private company clients include Ataxion, Constellation, Cydan, Denali, Fulcrum, Visterra and X-Chem. Mr. Singer has also worked with pharmaceutical companies, including Becton Dickinson, Bristol Myers Squibb, Novartis and Wyeth.

Mr. Singer has also worked with New York-based medical and academic institutions in the establishment and operation of an independent, nonprofit genome sequencing center and the Tri-Institutional Therapeutics Discovery Institute.